Common use of Certain Exercise Restrictions Clause in Contracts

Certain Exercise Restrictions. Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 9.999% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 8 with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 8 will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this provision shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 3 contracts

Sources: Series a Convertible Preferred Stock Purchase Agreement (Ortec International Inc), Warrant Agreement (Ortec International Inc), Warrant Agreement (Ortec International Inc)

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 9.9999.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 8 with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 8 will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this provision Section 8(a) shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 2 contracts

Sources: Warrant Agreement (Valcent Products Inc.), Warrant Agreement (Valcent Products Inc.)

Certain Exercise Restrictions. Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 9.999% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 8 7(b) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 8 7(b) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that . If the Holder elects to exercise this provision shall be of no further force or effect during the sixty-one Warrant and such exercise would result in such Holder beneficially owning (61in accordance with Section 13(d) days immediately preceding the expiration of the term Securities Exchange Act of this Warrant.1934, as amended, and the rules thereunder) more than 9.999% of all of the Common Stock

Appears in 1 contract

Sources: Series a Convertible Preferred Stock Purchase Agreement (Ortec International Inc)

Certain Exercise Restrictions. Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant the Holder exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder Holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 9.9994.999% of all of the Common Stock outstanding at such time; providedprovided , howeverhowever , that upon a holder of this Warrant providing the Issuer Corporation with sixty-one (61) days notice (pursuant to Section 13 hereof) (the "Waiver Notice") that such holder Holder would like to waive this Section 8 with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 8 will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this provision shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 1 contract

Sources: Warrant Agreement (Dc Brands International Inc)

Certain Exercise Restrictions. Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant the Holder exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 9.9999.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant the Holder providing the Issuer with sixty-one (61) days days’ notice (pursuant to Section 13 10.3 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 8 7 with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 8 7 will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this provision shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 1 contract

Sources: Warrant Agreement (VistaGen Therapeutics, Inc.)

Certain Exercise Restrictions. Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunderAct) in excess of 9.9994.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 8 with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 8 will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Noticesuch notice; provided, further, that this provision Section 8 shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 1 contract

Sources: Warrant Agreement (Implant Sciences Corp)